The Prevalence of Genital HPV and Factors Associated with Oncogenic HPV Among Men Having Sex with Men and Men Having Sex with Women and Men: the HIM Study

Overview

Journal Sex Transm Dis

Specialty Infectious Diseases

Date 2011 Sep 22

PMID 21934568

Citations 33

Authors

Alan G Nyitray

Roberto J Carvalho da Silva

Maria Luiza Baggio

Beibei Lu

Danelle Smith

Martha Abrahamsen

Mary Papenfuss

Manuel Quiterio

Luisa L Villa

Anna R Giuliano

Affiliations

Soon will be listed here.

Abstract

Background: Comparative studies of genital human papillomavirus (HPV) among men having sex with men (MSM), men having sex with women and men (MSWM), and men having sex with women (MSW) have not been conducted so far; however, such comparisons may be important for planning prevention strategies like vaccination.

Methods: Men, aged 18 to 70 years, were enrolled in a study of genital HPV in São Paulo, Brazil; Cuernavaca, Mexico; and Tampa, FL. Men were classified as MSM (n = 170), MSWM (n = 214), and MSW (n = 3326) based on self-reported sexual behavior. Genotyping for HPV was conducted on cells from the penis and scrotum. Prevalence data were adjusted by country. Factors potentially associated with genital HPV were assessed using multivariable Poisson regression.

Results: Genital HPV prevalence was typically higher among MSWM than among MSM or MSW for groups of HPV genotypes including nononcogenic types (51%, 36%, and 42%, respectively), and multiple types (37%, 24%, and 29%, respectively). Age and alcohol consumption in the past month were associated with oncogenic HPV among both MSM and MSWM; however, there were no statistically significant associations between sexual behaviors and genital HPV among MSM or MSWM.

Conclusions: Prevalence of genital HPV may be higher among MSWM than among MSW or MSM. Number of female sex partners was associated with genital HPV among MSW, but number of male anal sex partners was not associated with genital HPV among MSM and MSWM.

Citing Articles

Prevalence and concordance of oral and genital HPV by sexual orientation among US men.

Sonawane K, Shyu S, Damgacioglu H, Li R, Nyitray A, Deshmukh A JNCI Cancer Spectr. 2022; 7(1).

PMID: 36519821 PMC: 9825748. DOI: 10.1093/jncics/pkac088.

HPV screening in the urine of transpeople - A prevalence study.

Pils S, Mlakar J, Poljak M, Domjanic G, Kaufmann U, Springer S EClinicalMedicine. 2022; 54:101702.

PMID: 36263396 PMC: 9574404. DOI: 10.1016/j.eclinm.2022.101702.

Reducing Poverty-Related Disparities in Cervical Cancer: The Role of HPV Vaccination.

Spencer J, Brewer N, Coyne-Beasley T, Trogdon J, Weinberger M, Wheeler S Cancer Epidemiol Biomarkers Prev. 2021; 30(10):1895-1903.

PMID: 34503948 PMC: 8492489. DOI: 10.1158/1055-9965.EPI-21-0307.

Effectiveness of Human Papillomavirus (HPV) Vaccination Against Penile HPV Infection in Men Who Have Sex With Men and Transgender Women.

Winer R, Lin J, Querec T, Unger E, Stern J, Rudd J J Infect Dis. 2021; 225(3):422-430.

PMID: 34320185 PMC: 8842819. DOI: 10.1093/infdis/jiab390.

The characteristics and risk factors of human papillomavirus infection: an outpatient population-based study in Changsha, Hunan.

Gao B, Liou Y, Yu Y, Zou L, Li W, Huang H Sci Rep. 2021; 11(1):15128.

PMID: 34302031 PMC: 8302608. DOI: 10.1038/s41598-021-94635-1.

References

Nyitray A, Carvalho da Silva R, Baggio M, Lu B, Smith D, Abrahamsen M . Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis. 2010; 203(1):49-57. PMC: 3086435. DOI: 10.1093/infdis/jiq021. View

Markowitz L, Dunne E, Saraiya M, Lawson H, Chesson H, Unger E . Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56(RR-2):1-24. View

Deddens J, Petersen M . Approaches for estimating prevalence ratios. Occup Environ Med. 2008; 65(7):481, 501-6. DOI: 10.1136/oem.2007.034777. View

Giuliano A, Nielson C, Flores R, Dunne E, Abrahamsen M, Papenfuss M . The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis. 2007; 196(8):1146-52. PMC: 3904649. DOI: 10.1086/521629. View

van der Snoek E, Niesters H, Mulder P, van Doornum G, Osterhaus A, van der Meijden W . Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis. 2003; 30(8):639-44. DOI: 10.1097/01.OLQ.0000079520.04451.59. View

Greenland S, Neutra R . Control of confounding in the assessment of medical technology. Int J Epidemiol. 1980; 9(4):361-7. DOI: 10.1093/ije/9.4.361. View

. Human papillomavirus infection in men residing in Brazil, Mexico, and the USA. Salud Publica Mex. 2008; 50(5):408-18. PMC: 3495064. DOI: 10.1590/s0036-36342008000500014. View

Franceschi S, Castellsague X, Dal Maso L, Smith J, Plummer M, Ngelangel C . Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer. 2002; 86(5):705-11. PMC: 2375316. DOI: 10.1038/sj.bjc.6600194. View

Giuliano A, Lazcano E, Villa L, Flores R, Salmeron J, Lee J . Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer. 2008; 124(6):1251-7. PMC: 3466048. DOI: 10.1002/ijc.24097. View

10.

Giuliano A, Palefsky J, Goldstone S, Moreira Jr E, Penny M, Aranda C . Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med. 2011; 364(5):401-11. PMC: 3495065. DOI: 10.1056/NEJMoa0909537. View

11.

Gravitt P, Peyton C, Apple R, Wheeler C . Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998; 36(10):3020-7. PMC: 105104. DOI: 10.1128/JCM.36.10.3020-3027.1998. View

12.

Svare E, Kjaer S, Worm A, Osterlind A, Meijer C, van den Brule A . Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect. 2002; 78(3):215-8. PMC: 1744457. DOI: 10.1136/sti.78.3.215. View

13.

Lacey C, Lowndes C, Shah K . Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006; 24 Suppl 3:S3/35-41. DOI: 10.1016/j.vaccine.2006.06.015. View

14.

Winer R, Feng Q, Hughes J, OReilly S, Kiviat N, Koutsky L . Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis. 2008; 197(2):279-82. PMC: 2875685. DOI: 10.1086/524875. View

15.

Nielson C, Harris R, Dunne E, Abrahamsen M, Papenfuss M, Flores R . Risk factors for anogenital human papillomavirus infection in men. J Infect Dis. 2007; 196(8):1137-45. PMC: 3877918. DOI: 10.1086/521632. View

16.

Caceres C, Konda K, Pecheny M, Chatterjee A, Lyerla R . Estimating the number of men who have sex with men in low and middle income countries. Sex Transm Infect. 2006; 82 Suppl 3:iii3-9. PMC: 2576725. DOI: 10.1136/sti.2005.019489. View

17.

Spiegelman D, Hertzmark E . Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005; 162(3):199-200. DOI: 10.1093/aje/kwi188. View

18.

Seidman S, Rieder R . A review of sexual behavior in the United States. Am J Psychiatry. 1994; 151(3):330-41. DOI: 10.1176/ajp.151.3.330. View

19.

Miralles-Guri C, Bruni L, Cubilla A, Castellsague X, Bosch F, de Sanjose S . Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol. 2009; 62(10):870-8. DOI: 10.1136/jcp.2008.063149. View

20.

Backes D, Kurman R, Pimenta J, Smith J . Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2008; 20(4):449-57. DOI: 10.1007/s10552-008-9276-9. View